1. Home
  2. /
  3. Availability
  4. /
  5. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

Description

We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB vaccines in low- and middle-income countries (LMICs) for a range of product characteristics and delivery strategies.
Click to copy link of this headerMenu